Clin2
NCT06319872Possibly a fitRecruiting

Study of disulfiram for vision in retinal degeneration

Alcohol Use DisorderRetinal DystrophiesAge-Related Macular DegenerationRetinitis PigmentosaStargardt Disease

Part of Eyes & vision, Genetic & congenital, Mental health clinical trials.

This trial tests whether disulfiram, a drug used for alcohol use disorder, can improve vision in people with retinal degeneration. You must have an alcohol use diagnosis and agree to avoid alcohol for 6 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have an inherited retinal disease or dry age-related macular degeneration.
  • You have a diagnosis of alcohol use disorder and are a candidate for disulfiram therapy.
  • You agree to avoid all alcohol for 180 days.
  • You have vision ranging from 20/20 to light perception in your better eye.
  • You can take oral medication and follow the study schedule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06375239Recruiting
Study of tests for tracking vision in retinal disease

This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.

Irvine, California
NCT07419334Recruiting· Phase 3
Study of a new drug for Stargardt disease

This trial tests a new drug, ALK-001, to see if it can slow down vision loss from Stargardt disease. It is for people who have a confirmed genetic diagnosis and are between 8 and 45 years old.

Phoenix, Arizona
NCT06805474Recruiting
Study of a vision test for Stargardt and geographic atrophy

This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.

Dallas, Texas
NCT02018692Not yet recruiting· Phase 1/Phase 2
Algae powder for vision in teens with retinitis pigmentosa

This trial tests whether a powder made from a special algae can help improve vision in teenagers with retinitis pigmentosa, a genetic condition that causes vision loss. The algae contains a form of vitamin A that might protect the retina.

Tel Litwinsky
NCT03178149Recruiting· Phase 1
Study of a new eye treatment for dry macular degeneration

This Phase 1 trial tests the safety and side effects of ASP7317 in older adults whose central vision is worsening from dry age-related macular degeneration (geographic atrophy). If you qualify, you would receive treatment in the study eye and be closely monitored for about a year.

Phoenix, Arizona
NCT07502664Recruiting
A study on vision and navigation in inherited retinal disease

This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.

Irvine, California

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.